Cardiovascular Risk and Circadian Misalignment in Short Sleepers - Role of Extended Eating Period
Sponsored by Pennington Biomedical Research Center
About this trial
Last updated 2 years ago
Study ID
Status
Type
Phase
Placebo
Accepting
Trial Timing
Started 2 years ago
What is this trial about?
What are the participation requirements?
Inclusion Criteria
- Age: 18-45 years
- BMI: 25-35 kg/m2
- Habitual sleep duration: ≤6.5 h/night
- Habitual eating period: >14h/day
- Absence of chronic health conditions including hypertension (defined as systolic clinical BP of >140 or diastolic BP of >90 mmHg or use of BP lowering drugs), dyslipidemia (defined as LDL >190mg/dL or Triglycerides >400 mg/dL or use of lipid lowering medications), diabetes (defined as fasting glucose >126 mg/dL and /or HbA1C >6.5%, or use of glucose lowering medication), and cardiovascular disease. However, individuals with prehypertension, and/or prediabetes will be allowed to participate.
- Individuals with seasonal allergies will also be included.
- Women of child-bearing age will be allowed to participate if they agree to use acceptable birth control during the study period.
- Must be able to provide written informed consent.
- Ability to follow the prescribed eating duration and maintain habitual diet, sleep and physical activity.
- Use of certain mediations will be allowed including birth control, second generation antihistamines, antacids, acne-related ointments etc.
Exclusion Criteria
- Irregular sleep habits / night shift / rotating shift work in past 1 month.
- Frequent travel related jet lag.
- Pregnant/ breast-feeding/ history of irregular menstrual cycles.
- Sleep disorders such as insomnia (defined as Insomnia Severity Index score ≥15), and sleep apnea (overnight oximetry defined oxygen desaturation index of >10 events/h of sleep).
- Presence of excessive daytime sleepiness (defined as Epworth Sleepiness Scale score >10).
- Recent changes in body weight (≥5%) within 3 months.
- Uncontrolled depression and /or anxiety, history of psychosis or bipolar disorder.
- Uncontrolled depression and/or depression is defined as PHQ-9 score of ≥15 or a positive response for suicidal thoughts (Q9 of the PHQ-9 - any response other than not at all).
- Any medication or condition that, in the opinion of the medical investigator, could interfere with the study outcomes or put the subject at risk by participating in the study.
- Blood or plasma donation during the past 2 months.